DEF-3(g16/NY-LU-12) encodes a novel RNA binding protein isolated by positional cloning from an SCLC homozygous deletion region in 3p21.3 and, in parallel, as a dierentially expressed gene during myelopoiesis from FDCPmix-A4 cells. DEF-3(g16/NY-LU-12) is ubiquitously expressed during mouse embryogenesis and in adult organs while human hematopoietic tissues showed dierential expression. The mouse and human proteins are highly conserved containing two RNA recognition motifs (RRMs) and other domains associated with RNA binding and protein-protein interactions. A database search identi®ed related proteins in human, rat, C. elegans and S. pombe including the 3p21.3 co-deleted gene, LUCA15. Recombinant proteins containing the RRMs of DEF-3(g16/NY-LU-12) and LUCA15 speci®-cally bound poly(G) RNA homopolymers in vitro. These RRMs also show similarity to those of the Hu protein family. Since anti-Hu RRM domain antibodies are associated with an anti-tumor eect and paraneoplastic encephalomyelitis, we tested sera from Hu syndrome patients with the RRMs of DEF-3(g16/NY-LU-12) and LUCA15. These were non-reactive. Thus, DEF-3(g16/ NY-LU-12) and LUCA15 represent members of a novel family of RNA binding proteins with similar expression patterns and in vitro RNA binding characteristics. They are co-deleted in some lung cancers and immunologically distinct from the Hu proteins.
Introduction
Loss of heterozygosity involving 3p is one of the most frequent alterations in various epithelial neoplasms. Within this chromosomal arm, 3p21.3 appears to be an important target (Daly et al., 1993; Wei et al., 1996; van den Berg et al., 1996) (and references therein). We previously identi®ed a 3p21.3 homozygous deletion in the small-cell lung carcinoma (SCLC) cell line NIH-H1450 which overlapped two other deletions in the SCLCs, NIH-H740 and GLC20. In that report, we described the semaphorin, H.SemaIV, from the common deletion region and an unrelated cDNA, L1-204, from the site of the telomeric GLC20 breakpoint. Although L1-204 was evolutionarily conserved, it did not contain a signi®cant open reading frame. However, GRAIL predicted one coding segment which corresponded to a 74 bp exontrapping product. In an independent set of experiments using a retroviral gene-trap vector to identify differentially expressed genes during granulocytic and macrophage dierentiation of murine FDCPmix-A4 cells, we isolated sequences homologous to the trapped exon. This gene, initially called def-3 (Acc No X96701), was found to be downregulated during granulocytic dierentiation while persisting during macrophage development (Hot®lder et al., data to be presented elsewhere).
Sequences from a partial cDNA, corresponding to the same gene, had been deposited as g16 (#U50839) nearly simultaneously with our initial submission. Recently, Gure et al. (1998) identi®ed NY-LU-12/g16 by screening a cDNA expression library using an autologous antibody from a patient with adenocarcinoma of the lung. Of interest, these authors found that two of twenty-one lung cancer patients had reactive antibodies although no further characterization of the antibodies or biochemical analysis of the protein was performed.
In this report, we have examined the human and mouse DEF-3(g16/NY-LU-12) sequences and their RNA expression patterns. We also examined the expression of LUCA15, a highly similar and codeleted gene located immediately adjacent to DEF-3(g16/NY-LU-12) in 3p21.3. DEF-3(g16/NY-LU-12) and LUCA15 encode predicted RNA binding proteins since each contains two RNA recognition motifs (RRMs). While similar to Drosophila sex-lethal and elav, among mammalian proteins the RRMs of DEF-3(g16/NY-LU-12) and LUCA15 are most like those of the human Hu protein family. Interestingly, RRMs from Hu proteins are antigenic and associated with paraneoplastic encephalomyelitis and anti-tumor activity in some patients with SCLC. Antibodies from Husyndrome patients are directed against the RRM domains and cross-react with multiple Hu protein family members (reviewed in Okano and Darnell, 1997 ). Therefore, we tested the cross-reactivity of DEF-3(g16/NY-LU-12) and LUCA15 RRMs with Hu antisera and found them to be immunologically distinct.
As an initial characterization and con®rmation that the predicted RRMs actually bind RNA, we performed in vitro studies with RNA homopolymers and recombinant RRM polypeptides from DEF-3(g16/ NY-LU-12) and LUCA15. Both proteins speci®cally bound poly(G) RNA, in contrast to HuD which bound poly(A). With their overall similarity, this suggests they might have common targets in vivo. Finally, a database analysis indicated that DEF-3(g16/NY-LU-12) and LUCA15 are markedly similar to the rat RNA binding protein, S1-1, and its apparent human homologue (KIAA0122). Additional related proteins were identi®ed in C. elegans and S. pombe. Thus, DEF-3(g16/NY-LU-12) and LUCA15 are members of an evolutionarily conserved family of RNA binding proteins.
Results

Cloning and mapping of DEF-3(g16/NY-LU-12)
Two approaches led us to the identi®cation of DEF-3(g16/NY-LU-12). A mouse sequence of 450 bp (def-3, Acc No X96701) was isolated from the multipotent cell line, FDCPmix-A4, in a retroviral gene-trap approach to identify dierentially regulated genes during granulopoeisis (Hot®lder et al., in preparation) . Independently, a positional cloning approach involving an apparent cluster of breakpoints near the telomeric boundary of an SCLC 3p21.3 homozygous deletion led to isolation of a trapped exon from an incompletely spliced cDNA (L1-204) . This exon was nearly identical to sequences from the mouse clone which, in turn, identi®ed the partial cDNA in GenBank, g16 (Acc No U50839). As initially deposited, g16 lacked the trapped exon from L1-204. Both the human and mouse full-length cDNAs were subsequently isolated (Materials and methods). A primer pair, H29465, from the 3' end of DEF-3(g16NY-LU-12) was found to be commonly deleted in each of three SCLC cell lines, i.e., NCI-H740, GLC20 and NCI-H1450 (not shown). However, a Southern blot using a probe from 359 ± 1037 bp of DEF-3(g16/NY-LU-12) showed a homozygous deletion only in NCI-H1450 (Figure 1) . Thus, DEF-3(g16/NY-LU-12) is directly interrupted by both the NCI-H740 and GLC20 deletions.
Sequence analysis of DEF-3 identi®es a novel protein family
The human cDNA sequence (Acc No AF069517) of DEF-3(g16/NY-LU-12) predicts a 1123 amino acid nuclear protein of 129 kDa. Comparison with the mouse sequence (Acc No AJ006486) (Figure 2a) shows they are 89% identical and 93% similar at the amino acid level. Database searches identi®ed related proteins in human (LUCA15 and KIAA0122), rat (S1-1), C. elegans and S. pombe. All exhibit a similar domain structure including the order in which these domains occur, thus de®ning a novel protein family. Table 1 shows the similarities and amino acid positions for these various domains. Those domains common to each of the family members are the RRMs, zinc ®ngers and the C-ter region. The latter occupies approximately 70 amino acids and is rich in glycine, serine/threonine and arginine/lysine residues, a feature noted in a variety of RNA binding proteins (Birney et al., 1993) . A comparison of the various C-termini is shown in Figure 2b .
Two domains are unique to DEF-3(g16/NY-LU-12). The ®rst is the decamer repeat, located from amino acids 71 ± 330, which occurs more than 20 times. The most invariant amino acids in the repeats are DFRGRD with adjacent uncharged residues on either side. In certain repeats, RGR is substituted by RGG, a recognized motif (the RGG box) in some RNA binding proteins (Burd and Dreyfuss, 1994) . Thus this region, like the C-terminus, may participate in RNA binding. The second unique domain involves amino acids 14 ± 65 which shows 48% similarity/23% identity with the POZ (poxvirus and zinc ®nger) domain of ZF5 (Acc No D89859). This degree of similarity, while perhaps not striking, is comparable to that observed among other POZ domains. Moreover, in DEF-3(g16/NY-LU-12), the second zinc ®nger belongs to the C 2 H 2 class (CX 2-4 CX 3 FX 5 LX 2 HX 3,4 H). Zinc ®ngers of this class can be divided into subfamilies based on their N-terminal domains (reviewed in Grondin et al., 1996) . One of these subfamilies is de®ned by N-ter POZ domains, suggesting that this prediction is more likely to be correct. POZ domains are implicated in proteinprotein interactions (Bardwell and Treisman, 1994; Dong et al., 1996) and have been reported to inhibit binding of target sequences by zinc ®ngers (Kaplan and Calame, 1997; Numoto et al., 1993) .
Expression of DEF-3(g16/NY-LU-12) and LUCA15
Northern blots for DEF-3(g16/NY-LU-12) were performed with RNAs of both mouse and human derived tissues. A 450 bp mouse DEF-3(g16/NY-LU-12) probe corresponding to 1225 ± 1674 bp of the mouse gene was used in Figure 3a . During mouse embryogenesis (part a), and in adult non-hematopoietic Figure 1 A portion of DEF-3(g16/NY-LU-12) is retained in cell lines de®ning the telomeric border of the 3p21.3 common deletion in SCLC cell lines. DNA samples from a normal human control cell line (GM2644) and three SCLC cell lines (GLC20, NCI-H740 and NCI-H1450) with known homozygous deletions were digested with EcoRI or PstI. The resulting Southern blot was hybridized with a 678 bp DEF-3(g16/NY-LU-12) cDNA probe from bp 359 ± 1037 tissues (part b), expression appears constitutive. However, using the same probe against human hematopoietic RNAs, DEF-3(g16/NY-LU-12) expression is highest in certain lymphoid tissues (lymph node and thymus) while markedly lower in bone marrow.
These results are consistent with our initial ®ndings which suggested that DEF-3(g16/NY-LU-12) expression was reduced during granulocytic dierentiation. In peripheral blood leukocytes and also in fetal liver, two bands were observed. In support of this, several a b Figure 2 (a) Amino acid sequence of the human and mouse DEF-3(g16/NY-LU-12) genes. The human sequence is given in the upper line and dierences in the mouse sequence are noted below. The shaded boxes demarcate the amino acid positions (given in parentheses) of following consecutive domains: POZ (14-65), decamer repeats (70 ± 330), RRMI (445 ± 533), ZnFl (542 ± 559), RRM2 (652 ± 744), octamer repeats (790 ± 813), KEKE motif (850 ± 862), coiled-coil (934 ± 956), ZnF2 (957 ± 980), coiled-coil (981 ± 1003), nuclear localization signal (1015 ± 1031) and the Gly, Ser/Thr, Arg/Lys rich C-ter (1052 ± 1123). (b) Alignment of C-termini from DEF-3(g16/NY-LU-12) and family members. Genbank accession numbers are LUCA15 (#U23946), KIAA0122 (#D50912), S1-1 (#D83948), C. elegans gene (1947021 in #AF000263) and S. pombe gene (2104448 in #Z95396) The numbers in the columns refer to the amino acid positions of the domains in their respective proteins. The per cent values indicate the similarity of each domain compared to LUCA15, initially identi®ed as Gene15 (Wei et al., 1996) , which was used as the base of comparison since it has an overall higher similarity to the others and because it contains an amphipathic domain present in some members, but absent in DEF-3(g16/NY-LU-12). The POZ and decamer repeats are unique to DEF-3(g16/NY-LU-12) splicing variants were identi®ed in the cDNA database (dbEST) which signi®cantly alter the predicted protein (e.g., EST AA934109, AA442117).
In additional experiments, DEF-3(g16/NY-LU-12) expression was directly compared to LUCA15 by sequential hybridizations of the same ®lter (Clontech). Overall, the expression patterns for both DEF-3(g16/ NY-LU-12) and LUCA15 are similar. Figure 3d shows that both genes are most highly expressed in heart while expression in lung and kidney was barely detectable. This near absence of expression in lung and kidney was partially due to less RNA present in those lanes as determined by a control G3PDH probe (not shown). For DEF-3(g16/NY-LU-12), the relative intensities of the *4 and 5 kb bands vary considerably among dierent tissues. Two bands are also evident for LUCA15, although their nearly constant relative intensities and considerable size dierence suggests that the larger band is incompletely spliced. To further extend the expression analysis, a dot blot (Clontech) representing 50 tissues was sequentially hybridized and quantitated by phosphorimaging. For comparison, the counts from all 50 tissues were averaged and each compared to the mean. Like the Northern analysis, expression levels of the two genes were quite similar (not shown). Highest levels were seen in adult thymus (DEF-3(g16/NY-LU-12), 224% of the mean; LUCA15, 179%) and fetal kidney (DEF-3(g16/NY-LU-12), 183%; LUCA15, 176%). In contrast, levels in the fetal thymus and adult kidney counterparts were among the lowest expressing tissues: fetal thymus (DEF-3(g16/NY-LU-12), 72%; LUCA15, 79%) and adult kidney (DEF-3(g16/NY-LU-12), 67%; LUCA15, 79%). These results suggest that dierential expression of DEF-3(g16/NY-LU-12) and LUCA15 occurs during development of non-hematopoietic organs as well. The most marked dierence between the two genes was in adult frontal lobe where DEFFigure 3 DEF-3(g16/NY-LU-12) expression in mouse and human tissues. RNA was isolated from fetal mice at the indicated gestational times (a) or from adult tissues (b). Human RNAs from the indicated tissues are shown in (c). The ®lters were hybridized with a mouse DEF-3(g16/NY-LU-12) probe corresponding to bp 1225 ± 1674. The arrows indicate two RNA products present in human samples. b-actin was used as control (bottom panels). A separate Clontech blot (d) was sequentially hybridized with human LUCA15 and DEF-3(g16/NY-LU-12) probes corresponding to bp 2055 ± 2561 and 1037 ± 1015, respectively (see Materials and methods) 3(g16/NY-LU-12) was 135% of the mean compared to 55% for LUCA15.
Binding of RRM domains to RNA and reactivity with anti-Hu sera Sequence similarities in the RRM domains of RNA binding proteins have been reported to predict functional similarities among these proteins (Kim and Baker, 1993) . BLAST searches and tertiary structural alignments showed the DEF-3(g16/NY-LU-12) and LUCA15 RRMs to be most closely related to RRMs from Drosophila sex-lethal (Sxl). Among mammalian proteins, the most related RRMs are those from the Hu protein family. Hu proteins bind the 3' UTRs of some growth factor and cytokine messages resulting, where known, in increased stability (Gao et al., 1994; Levine et al., 1993) . In patients with SCLC, anti-Hu antibodies (which cross-react with multiple Hu protein family members) appear to be associated with an antitumor activity and in some cases result in paraneoplastic encephalomyelitis (Okano and Darnell, 1997; Graus et al., 1997) . Figure 4 shows a comparison of the second RRM from DEF-3(g16/NY-LU-12) and LUCA15 to the ®rst RRM of HuC. The overall structural organization, babbab, is conserved (Burd and Dreyfuss, 1994) . The b sheets containing the conserved octamer (RNP1) and hexamer (RNP2) motifs are believed to provide a general RNA binding surface whereas more speci®city is provided by the variable loop segments and boundaries of the RRM domain (Burd and Dreyfuss, 1994) .
Recombinant proteins containing the RRMs of DEF-3(g16/NY-LU-12) and LUCA15 were produced in bacteria (Materials and methods). After anity chromatography, the proteins appeared either essentially pure by Coomassie staining, or they contained one or more faint lower bands which reacted with anti-T7 Tag antibodies and therefore represented truncated products (i.e., the T7 tag epitope is encoded by the pRSET vector in the N-terminus of the fusion protein). The predicted sizes of the recombinant proteins were *44, 33 and 45 kDa for DEF-3(g16/NY-LU-12), LUCA15 and HuD, respectively, which matched their migration in SDS-polyacrylamide gels. The DNA constructs were used to produce in vitro transcribed/ translated 35 S-labelled proteins for binding to RNA homopolymers and the puri®ed proteins from bacteria were used to test cross-reactivity with anti-Hu sera. As a negative control for RNA binding, we prepared labelled ®re¯y luciferase protein (61 kDa) using the template provided in the TnT kit (Materials and methods).
The results of the RNA binding studies are shown in Figure 5 . Preferential binding was observed by the DEF-3(g16/NY-LU-12) and LUCA15 RRM domains to poly(G) RNA (lanes 14, 16 and 20, respectively) at near physiologic salt concentration (0.1 M NaCl, pH 7.5). Of note, the DEF-3(g16/NY-LU-12)/LUCA15 family member S1-1 (rat homologue of human KIA0122) was previously shown to bind G and U polyribonucleotides (Inoue et al., 1996) . In contrast, HuD was found to bind poly(A) RNA (lane 6) in agreement with its reported binding to speci®c A+U-rich substrates (Okano and Darnell, 1997; Gao et al., 1994) . No binding was observed by the 61 kDa ®re¯y luciferase (lanes 27 ± 33). For DEF-3(g16/NY-LU-12), we tested its binding to poly(G) RNA at high salt (0.5 M NaCl, pH 7.5) and found it was inhibited (lane 17). Finally, to exclude the possibility that the observed binding was due to a contaminating intermediate protein from the reticulocyte lysate, we performed a UV cross-linking experiment. In this procedure, only proteins in direct contact with nucleic acid are covalently cross-linked to it by UV exposure. After incubation of DEF-3(g16/NY-LU-12) with poly(G) RNA, UV exposure resulted in signi®cantly less recoverable protein from the beads after boiling in SDS-containing sample buer (lane 19). Based on the presence of the structurally conserved RRM domains and these biochemical results, we conclude that DEF-3(g16/NY-LU-12) is an RNA binding protein. No signi®cant binding was observed with either singlestrand or double-strand DNA (not shown).
Because the RRMs of DEF-3(g16/NY-LU-12) and LUCA15 show similarity to those of the Hu proteins, we asked whether anti-Hu antibodies would be crossreactive. High titer sera from ten patients with the Hu syndrome were tested by Western blotting against the recombinant RRMs from DEF-3(g16/NY-LU-12), LUCA15 and, as a positive control, HuD. Four representative samples for DEF-3(g16/NY-LU-12) are shown in Figure 6 . While all the anti-Hu sera were reactive to HuD, no cross-reaction was detected against DEF-3(g16/NY-LU-12). Identical results were obtained for LUCA15 (not shown). Control sera showed no reactivity against any of the proteins (not shown). Thus, while the RRMs of DEF-3(g16/NY-LU-12) and LUCA15 are similar to those from HuD, they are immunologically distinct.
Discussion
RNA-binding proteins regulate basic aspects of RNA metabolism such as capping, polyadenylation, transport, splicing, stability and translation (reviewed in Burd and Dreyfuss, 1994; Singh et al., 1995) . The presence of two RNA recognition motifs in DEF-3(g16/NY-LU-12) suggested it would bind RNA. Figure 4 Alignment of RRM domains from DEF-3(g16/NY-LU-12), LUCA15 and HuC. Black and shaded boxes indicate identity and similarity, respectively. Lines above the alignment indicate the predicted secondary structures. The topmost line corresponds to DEF-3(g16/NY-LU-12) and so-forth. Conserved residues as given by Birney et al. (1993) are listed below the alignment where U indicates uncharged and Z indicates uncharged, S, or T RRMs comprise 80 ± 90 amino acids and include an octapeptide, RNP1 and a hexapeptide, RNP2 located in the ®rst and third b-sheets (Singh et al., 1995; Kenan et al., 1991; Kim and Baker, 1993; Birney et al., 1993) . From X-ray crystallographic and other studies, each RNP binds 5 ± 7 speci®c nucleotides (Oubridge et al., 1994) . The length of intervening loops and the distribution of basic amino acids adds to the stability of RNA-binding. Using recombinant proteins produced by in vitro transcription/translation, we have demonstrated that the DEF-3(g16/NY-LU-12) RRMs, as well as LUCA15, are capable of speci®cally binding poly(G) RNA. For DEF-3(g16/NY-LU-12), this binding occurred at physiologic but not elevated salt concentrations and the UV cross-linking studies con®rmed that the binding was directly due to DEF-3(g16/NY-LU-12). In similar studies, the related rat S1-1 protein was shown to bind poly(G) and poly(U) RNA (Inoue et al., 1996) . While the homopolymer studies demonstrate that these proteins can bind RNA they are not designed to identify more speci®c in vivo targets.
Interestingly, similarity among RRMs is associated with functional similarity (Kim and Baker, 1993) . For instance, the RRMs of proteins associated with hnRNAs are more similar to each other than to the RRMs of proteins involved in dierentiation (Kim and Baker, 1993) . In vertebrates, Hu-family proteins bind to A+U rich destabilizing elements in the 3'UTRs of certain growth factor and cytokine messages aecting message stability (Gao et al., 1994; Levine et al., 1993) . Thus for example, we might expect DEF-3(g16/NY-LU-12) to be involved in the regulation of splicing or message stability instead of RNA transport. Consistent with this possibility, we found DEF-3(g16/NY-LU-12) was down-regulated during granulocytic dierentiation in FDCPmix-A4 cells while it persisted during macrophage formation (Hot®lder et al., in preparation). During hematopoiesis, certain key transcription factors are regulated by alternative splicing. For example, Ikaros is an alternatively spliced zinc ®nger transcription factor required for lymphoid development which, when knocked out, results in an excess of monocytes and macrophages . In our Northern analysis, DEF-3(g16/NY-LU-12) expression was considerably higher in certain lymphoid tissues (thymus and lymph node) compared to bone marrow which is predominantly composed of myeloid and erythroid lineages. DEF-3(g16/NY-LU-12) is predicted to be a nuclear factor based on its nuclear localization signal. Also, its coiled-coil, zinc ®nger, KEKE and putative POZ domains suggests it might interact with several proteins.
DEF-3(g16/NY-LU-12) and the related LUCA15 are co-deleted in three SCLC cell lines with homozygous deletions involving 3p21.3. We have shown that DEF-3(g16/NY-LU-12) is located at the telomeric boundary of the common deletion region de®ned by these SCLCs. The Hu syndrome is a paraneoplastic neuropathy and encephalomyelitis associated with high-titre antibodies directed against the RRMs of Hu-proteins (Dalmau et al., 1992) . In the majority of reported cases, the associated tumor was lung cancer and most were small-cell carcinomas, although adenocarcinoma was also observed (Dalmau et al., 1992) . High titre anti-Hu antibodies appear to confer an anti-tumor eect (Dalmau et al., 1992) and even low-titre antibodies, which occur in 16% of SCLC patients, have apparent anti-tumor activity (Graus et al., 1997) . It is interesting in this regard that while no mutations in HuD were observed in lung cancers (Sekido et al., 1994) , another Hu family gene, Hel-N1, is located in a novel deletion region on 9p (Cairns et al., 1997) . Therefore, we were interested in determining if anti-Hu antibodies cross-reacted with the DEF-3(g16/NY-LU-12) or LUCA15 RRMs. Our ®ndings demonstrate they do not.
During preparation of this manuscript, GuÈ re et al. (1998) identi®ed NY-LU-12/g16, the same gene as DEF-3(g16/NY-LU-12), on the basis of an autologous antibody from a patient with adenocarcinoma of the lung. No tumor speci®c mutation was identi®ed in NY-LU-12/g16 as a possible explanation for the reactive antibodies although LUCA15 was not examined. Moreover, these authors found that two of 21 lung cancer patients had anti-NY-LU-12/g16 antibodies. The cDNA clone which reacted with the patient's serum was reported to contain 952 nucleotides of C-ter coding sequence. While this would exclude the RRM domain as targets, the Cter region demonstrates considerable similarity among DEF-3(g16/NY-LU-12) related family members. Thus, it is possible that anti-DEF-3(g16/NY-LU-12) antibodies might be cross-reactive against LUCA15. We previously reported that two of 19 adenocarcinomas contained homozygous deletions using a FISH probe from the H.SemaIV locus, also within the 3p21.3 deletion (Varella-Garcia et al., 1997) . If anti-DEF-3(g16/NY-LU-12) or anti-LUCA15 antibodies have an anti-tumor eect, then a co-deletional event would remove both potential cross-reactive antigens. Also, the deletions we observed occurred in only a portion of the tumor cells and would likely be missed by PCR. Thus, it is possible that an anti-tumor eect from antibodies, or other forms of immunity, directed against DEF-3(g16/NY-LU-12) or LUCA15 might occur in some patients with lung cancer.
Materials and methods
Cloning of DEF-3(g16/NY-LU-12)
A 74 bp trapped exon from the cDNA clone L1-204 was 99% identical to a partial mouse def-3 sequence (Acc No X96701) which, in turn, provided linkage to the human g16 partial cDNA deposited by Latif et al. (U50839) . From analysis of dbEST, clone zq05f07.s1 from a Stratagene muscle cDNA library was obtained and completely sequenced. For the 5' end, nested gene speci®c primers 5'-TCC CCT CCT CGA TAG TCA CC and 5'-CCA TAG CTG AAA GAA TGC TCC were used with T3 and T7 vector primers (each at 1 mM) to amplify products from DNAs prepared from a fetal brain cDNA library (Statagene, #936206). PCR reactions were performed under 658C-558C touch-down conditions (DT of 71.08C per 2 cycles for 20 cycles, followed by 15 cycles at 558C). Products were cloned into a T-vector prepared from pBluescript II KS and sequenced on an ABI377 through the University of Colorado Cancer Center DNA Sequencing Core.
The mouse DEF-3(g16/NY-LU-12) sequence from nucleotides 1225-3593 (Acc No AJ006486) was assembled from our original clone, mdef-3 (Acc No X96701), and two ESTs (Acc Nos AA268319 and AA086694); the latter was obtained from the UK HGMP Resource Centre (Cambridge) and its complete sequence determined. A gap between the ESTs was bridged by RT ± PCR using brain mRNA isolated from strain C57/Bl/6 and gene speci®c primers GSP3 (5'-ATG AAC TCA GGA AAC GGC ACG) and GSP6 (5'-AGG CTT CCC CTC ACT GGT ACT TT). The products were diluted 1 : 10 and reampli®ed under the same conditions using internal primers GSP4 sense, 5'-AGG GAA GGG CT-T ACT TTC CGA and GSP5 antisense, 5'-TTG CTA TTT -GAC TTT CCT TGA CTG GTA. For these experiments, RNA was prepared using the QuickPrep Micro mRNA Puri®cation Kit (Pharmacia, Cat No 27-9255-01) and reverse transcription was performed on random primed template as per the 5' RACE system Version 2.0 protocol (Gibco, Cat No 18374-058) . PCR conditions included 30 cycles for each round, an annealing temperature of 598C and Exo 7 Pfu DNA polymerase and buer (Stratagene, Cat No 600163) . The ®nal products were cloned into the T-vector, pCR2.1 (Invitrogen, Cat No K2030-01) and sequenced using the LI-COR 4200 System (MWG-Biotech, UK).
Nucleotides 1 ± 264 were obtained by RACE using nested gene speci®c primers GSP25 [5'-TCC ATA GCT GAA AGA ATG CTC C-3'] and GSP32 [5'-AAA GGG AGG TCC TGA ATG CCC CTG GAA ATC-3'] corresponding to nt 411 ± 432 and nt 370 ± 399 respectively, of the human gene. The forward RACE primer was the Abridged Anchor Primer (Gibco, 5'-GGC CAC GCG TCG ACT AGT ACG GGI IGG GII GGG IIG-3'). A separate Race primer was used for the second stage PCR; the Abridged Universal Anchor Primer (5'-GGC CAC GCG TCG ACT AGT AC-3'). Nucleotides 654 ± 1224 were similarly obtained by RACE using gene speci®c primers GSP1 (5'-TCT GGA ACC CCA CTT AAT CGA ATA A-3') and GSP2 (5'-TTC TTT AAA CAG ACC AGC GTC TGA A-3'). For both experiments, PCR conditions consisted of [948C 2 min, (948C61 min, 558C 1 min, 688C62 min) for 30 cycles, 728C610 min] with the LA Taq and buer System Takara Shuzo Co., Biowhittaker UK Ltd). Final products were cloned into the pGEMT vector for sequencing. The remaining nucleotides 265 ± 653 were from mouse EST sequence (Acc No AF064939) kindly provided by Dr C Kappen (Scottsdale, AZ, USA).
Cloning and puri®cation of bacterially produced RRM proteins
The following PCR primers, forward (5'-GGA ATT C-GA TGC CCA ACG GGA C) and reverse (5'-AAC -TAA AGC TTA GCA TAA TCT GGA ACA TCA TAT-GGA TAG TGG TCA GAA TGG TC) containing EcoRI and HindIII sites, respectively, were used to amplify a segment containing both RRMs from amino acids 435 ± 752 of DEF-3(g16/NY-LU-12). The reverse primer also contained an HA-tag.DNA from a colony puri®ed cDNA clone of zq05f07.s1 served as template. The PCR products were digested with EcoRI and HindIII, cloned in-frame using the bacterial expression vector, pRSETB (Invitrogen), and veri®ed by DNA sequencing. This construct which includes vector derived T7 Tag and polyhistidine segments along with the HA-tag and 17 amino acids of downstream vector sequences is expected to produce a protein of approximately 44 kDa. Recombinant protein was produced in BL211ys S cells (Novagen) and puri®ed using a Talon resin (Clontech) with imidazole-based buers for native 6xHis protein puri®cation as recommended by the manufacturer (Protocol #PT1320-1) .
Similarly, the entire HuD coding sequence and the LUCA15 sequence from amino acids 90 ± 357 which includes both RRM domains were PCR ampli®ed from fetal brain cDNA library DNA as above and cloned into pRSETB. Sequence veri®ed constructs were expressed and puri®ed as above except that recombinant HuD protein appeared to require puri®cation in denaturing conditions for optimal yields. The primer sequences were HuD_for (CGG GAT CCG GTT ATG ATA ATT AGC ACC ATG-G), HuD_rev (CTC CCG CTC GAG TCA GGA CTT-GTG GGC TTG G), LUCA15_AA90_for (CGG GAT CC-G ATC AGT GAC GAG AGG GAG AGC) and LUCA 15_AA357_rev (CTC CCG CTC GAG TCA GTC AAC-ACT GAC TCC TTC ACC AC). The predicted sizes of the recombinant proteins were 45 kDa for HuD and LUCA15, 33 kDa.
Western blots and testing of anti-HuD antisera
Recombinant DEF-3(g16/NY-LU-12), LUCA15 and HuD proteins were separated on 12% SDS-polyacrylamide (29 : 1) gels and transferred to nitrocellulose ®lters. Blocking was performed with 1% (wt/vol) I-BLOCK (Tropix, Bedford, MA, USA) overnight, washed three times (5 min each) in phosphate buered saline (PBS), and incubations with primary antibodies were carried out in PBS containing 0.1% (vol/vol) Tween-20 for 1 h at room temperature. The ®lters were washed as above, then similarly incubated with alkaline phosphatase conjugated secondary antibodies. After ®nal washing the ®lters were developed using Pierce (Rockford, IL, USA) 1-step NBT/ BCIP. The primary antibodies were: (1) T7 Tag (Novagen, Madison, WI, USA, #69522-3) at 1:10 000 dilution, a mouse monoclonal directed at the T7 gene 10 leader sequence encoded by pRSEB; (2) 12CA5 (BoehringerMannheim, #1583816) at 1 mg/ml, a mouse monoclonal directed at the HA peptide; (3) human sera from ten SCLC patients with the Hu syndrome, previously documented to contain anti-HuD antibodies, used at 1:1000 dilution. The secondary antibodies were: (1) rabbit anti-mouse AP-F(ab') 2 , used at 1:5000 dilution (Zymed, San Francisco, CA, USA, #61-6322); (2) goat anti-human IgG used at 1:2500 dilution (Jackson ImmunoResearch Labs, #109-055-003).
Binding of RRM proteins to RNA Homopolymers
The pRSETB constructs described above were used as templates for the production of 35 S-labelled protein by in vitro transcription/translation with the TnT System (Promega, Madison, WI, USA) under conditions speci®ed by the manufacturer. As a negative control for RNA binding, ®re¯y luciferase (61 kDa) was translated using the template provided in the TnT kit. Binding of 35 S-labelled proteins to poly(A) (Sigma #P-8708), poly(U) (Sigma #P-8563), poly(G) (Sigma #P-1908) and poly(C) (Sigma #P-9827) RNA homopolymers was performed as utilized by Ohno et al. (1994) . Binding was similarly examined using single-stranded (Sigma #D-8273) and double-stranded (Sigma #D-8151) DNA resins. The control resins were Sepharose CL-4b-200 (Sigma), Cellex 410 cellulose powder (BioRad Labs) and polyacrylhydrazido-agarose (Sigma #P-9282). Ten per cent of the in vitro transcription/translation reaction in 0.5 ml of 0.1 M NaCl/10 mM Tris (pH 7.5) was added to 25 ml of each resin previously equilibrated in 0.1 M NaCl/10 mM Tris (pH 7.5) and another 10% was saved for direct loading on the gel. The mixture was rotated at 48C for 1 h, then brie¯y pelleted and the supernatant removed. The resin was brie¯y washed two times with 0.5 ml of 0.1 M NaCl/10 mM Tris (pH 7.5), then two more times for 20 min each. In a separate experiment with DEF-3(g16/NY-LU-12), binding to the poly(G) homopolymer was tested in the presence of 0.5 M NaCl/10 mM Tris (pH 7.5), but washed as above. Forty ml of 16SDS ± PAGE sample buer was added to the washed resins and heated in a 1008C dry block for 5 min. Samples were electrophoresed in a 9% polyacrylamide gel, ®xed in 10 volumes of 10% (vol/vol) glacial acetic acid for 20 min and neutralized in a dilute (4 mM) NaOH solution (until the bromophenol blue dye began to return to a blue color). The gel was soaked in 1 M salicylate for 30 min, dried and exposed to Kodak X-OMAT AR ®lm. For the UV cross-linking experiments, following the binding and washing of 35 S-labelled DEF-3(g16/NY-LU-12) with the poly(G) homopolymer or control polyacrylhydrazido-agarose, the washed resin was placed in a petri dish and exposed to emissions from a 15-watt germicidal lamp (Sylvania G15T8, GTE Sylvania Inc, Danvers, MA, USA) at a distance of 4.5 cm for 10 min. Non-covalently bound DEF-3(g16/ NY-LU-12) was recovered and analysed as above.
Cell lines, probes and hybridizations
The SCLC cell line GLC20 (Kok et al., 1994) was kindly provided by Dr Charles Buys. The SCLC lines NCI-H740 and NCI-H1450 were obtained through the University of Colorado Lung Cancer SPORE and Drs Adi Gazdar and John Minna. DNA from the human cell line GM2644 was used as a normal control. The cell lines were grown in RPMI-1640 containing 10% fetal calf serum. For Southern blot analysis of DEF-3(g16/NY-LU-12), a 677 bp probe was generated using the primers 5'-CAC TTC CCT TTG ATT TCC AG (bp 359 ± 378) and 5'-TAC AAG ATC CCA TCT CTC TGC C (bp 1037 ± 1015) with the PCR conditions described above. For LUCA15, a PCR derived probe was obtained from bp 2055 ± 2561 (accession #U23946) using the forward and reverse primers 5'-GAC CAC TTC TTG TGC TCC TTG and 5'-AGT CAG GCA CCA GCA ACA CT. The H29465 primers from the 3' portion of DEF-3(g16/NY-LU-12) (bp 2791 ± 2871) were 5'-TTT CAG GAA AAT GC-C AGT GA and 5'-TTC CTT CTT CAC AGT AG-G AGG C. Southern blot hybridizations were performed at 658C using a charged nylon membrane (Amersham) in Amasino buer (Amasino, 1986) . Washings were performed two times for 15 min at 658C in 0.16SSC/0.1% SDS. Northern blots containing approximately 2 mg of poly(A) + RNA per lane from human and mouse tissues, as well as a human RNA dot blot (RNA Master blot), were obtained from Clontech and utilized under conditions suggested by the supplier.
DNA sequence analysis
Protein motifs were found using the PRINTS protein motif ®ngerprint database (http://www.biochem.ucl.ac.uk/bsm/ dbbrowser/PRINTS/PRINTS.html), Statistical Analysis of Protein Sequences at the Swiss Institute for Experimental Cancer Research (ISREC) (http://ulrec3.unil.ch/software/ SAPS_form.html), and through alignments of DEF-3(g16/ NY-LU-12) family members using the FASTA and BESTFIT programs from the GCG package. Coiled-coils were located using COILS at ISREC (http://ulrec3.unil.ch/ software/COILS_form.html). Secondary structure was predicted using the Baylor College of Medicine SSP program (http://dot/imgen.bcm.tmc.edu:9331/pssprediction/pssp.html), and tertiary structure alignments were done using the UCLA-DOE fold recognition server (http://fold/doe-mci.ucla.edu/Home). Database searches for homologs were conducted using the BLAST server at NIH.
